Variants in the CYP2B6 3'UTR Alter In Vitro and In Vivo CYP2B6 Activity: Potential Role of MicroRNAs.
Variants in the CYP2B6 3'UTR Alter In Vitro and In Vivo CYP2B6 Activity: Potential Role of MicroRNAs.
复制标题
DOI:
10.1002/cpt.892
复制
发表时间:
2018-07
影响因子:
6.7
通讯作者:
Skaar TC
中科院分区:
文献类型:
--
作者:
Burgess KS;Ipe J;Swart M;Metzger IF;Lu J;Gufford BT;Thong N;Desta Z;Gaedigk R;Pearce RE;Gaedigk A;Liu Y;Skaar TC
CYP2B6*6 and CYP2B6*18 are the most clinically important variants causing reduced CYP2B6 protein expression and activity. However, these variants do not account for all variability in CYP2B6 activity. Emerging evidence has shown that genetic variants in the 3′UTR may explain variable drug response by altering microRNA regulation. Five 3′UTR variants were associated with significantly altered efavirenz AUC0-48 (8-OH-EFV/EFV) ratios in healthy human volunteers. The rs70950385 (AG>CA) variant, predicted to create a microRNA binding site for miR-1275, was associated with 33% decreased CYP2B6 activity among normal metabolizers (AG/AG vs. CA/CA [p<0.05]). In vitro luciferase assays were used to confirm that the CA on the variant allele created a microRNA binding site causing a 11.3% decrease in activity compared to the AG allele when treated with miR-1275 (p=0.0035). Our results show that a 3′UTR variant contributes to variability in CYP2B6 activity.
登录
查看更多内容
影响因子:
44.1
作者:
Shi, YY;He, L
通讯作者:
He, L
影响因子:
8.8
作者:
Kharasch ED;Regina KJ;Blood J;Friedel C
通讯作者:
Friedel C
影响因子:
2.6
作者:
Nakajima, Miki;Komagata, Sayaka;Minami, Hironobu
通讯作者:
Minami, Hironobu
DOI:
10.1038/tpj.2013.17
发表时间:
2014-04
期刊:
The pharmacogenomics journal
影响因子:
--
作者:
Michaud V;Kreutz Y;Skaar T;Ogburn E;Thong N;Flockhart DA;Desta Z
通讯作者:
Desta Z
影响因子:
3.4
作者:
Jiang, Fen;Desta, Zeruesenay;Shin, Jae-Gook
通讯作者:
Shin, Jae-Gook